(Q42013514)

15 October 2017

Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide (English)

1 reference

15 October 2017

D Hartmann

1

1 reference

15 October 2017

A Korn

2

1 reference

15 October 2017

M Komjati

3

1 reference

15 October 2017

G Heinz

4

1 reference

15 October 2017

P Haefelfinger

5

1 reference

15 October 2017

R Defoin

6

1 reference

15 October 2017

W K Waldhäusl

7

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 August 1990

1 reference

British Journal of Clinical Pharmacology

15 October 2017

1 reference

15 October 2017

30

1 reference

15 October 2017

2

1 reference

15 October 2017

245-252

1 reference

Effect of naproxen on glucose metabolism and tolbutamide kinetics and dynamics in maturity onset diabetics

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Metabolic effects of prostaglandin E2 infusion in man: possible adrenergic mediation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Effect of pirprofen on glibenclamide kinetics and response

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Oral hypoglycaemic agents. An update

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Hypothesis: PGE, Carbohydrate Homeostasis, and Insulin Secretion: A Suggested Resolution of the Controversy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Oxicams--a novel family of non-steroidal anti-inflammatory drugs

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Lack of effect of tenoxicam on glibornuride kinetics and response

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368224

Sounding board. Prostaglandins, the glucoreceptor, and diabetes

5 June 2018

1 reference

12 December 2020

Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay

1 reference

12 December 2020

Discrepant effect of the prostaglandin synthesis inhibitor acetylsalicylic acid on insulin and C-peptide response to glucose in man

1 reference

12 December 2020

Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N)

1 reference

12 December 2020

The pharmacokinetics of glibenclamide: a single dose comparison of four preparations in human volunteers

1 reference

12 December 2020

Determination of tenoxicam in human plasma by high-performance liquid chromatography

1 reference

12 December 2020

Pharmacokinetics of tenoxicam in healthy human volunteers

1 reference

12 December 2020

High-performance liquid chromatographic determination of glibenclamide in human plasma and urine

1 reference

12 December 2020

Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man

1 reference

12 December 2020

10.1111/J.1365-2125.1990.TB03771.X

Identifiers

DOI

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

2119677

1 reference